Institutional Ownership Avidity Biosciences, Inc. (RNA)
This table provides information about the institutional ownership of Avidity Biosciences, Inc. (RNA). We have compiled data on the 258 institutions that hold shares in the stock, with a total of 108 Million shares, which have been reported (via 13F filing form) to have a value of $3.33 Billion.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Bio Impact Capital LLC
Cambridge, MA |
Feb 14, 2025 Q4 2024 |
702,981
shares
|
$21.7 Million
3.06% of portfolio
|
Q4 2024
Added 2.03%
|
|
Dimensional Fund Advisors LP
Austin, TX |
Feb 13, 2025 Q4 2024 |
674,256
shares
|
$20.8 Million
0.0% of portfolio
|
Q4 2024
Added 0.32%
|
|
D. E. Shaw & Co., Inc.
New York, NY |
Feb 14, 2025 Q4 2024 |
558,969
shares
|
$17.2 Million
0.01% of portfolio
|
Q4 2024
Reduced 49.58%
|
|
Eco R1 Capital, LLC
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
557,576
shares
|
$17.2 Million
0.76% of portfolio
|
Q4 2024
Reduced 26.4%
|
|
Silverarc Capital Management, LLC
|
Feb 14, 2025 Q4 2024 |
543,651
shares
|
$16.8 Million
3.8% of portfolio
|
Q4 2024
Added 14.32%
|
|
Jpmorgan Chase & CO
New York, NY |
Feb 12, 2025 Q4 2024 |
450,144
shares
|
$13.9 Million
0.0% of portfolio
|
Q4 2024
Reduced 3.63%
|
|
Man Group PLC
London, X0 |
Feb 14, 2025 Q4 2024 |
422,421
shares
|
$13 Million
0.03% of portfolio
|
Q4 2024
Reduced 53.59%
|
|
Alethea Capital Management, LLC
San Diego, CA |
Feb 14, 2025 Q4 2024 |
420,871
shares
|
$13 Million
10.51% of portfolio
|
Q4 2024
Reduced 1.54%
|
|
Td Asset Management Inc
|
Feb 11, 2025 Q4 2024 |
415,172
shares
|
$12.8 Million
0.01% of portfolio
|
Q4 2024
Reduced 4.55%
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Feb 14, 2025 Q4 2024 |
411,675
shares
|
$12.7 Million
0.0% of portfolio
|
Q4 2024
New holding
|
|
Fiera Capital Corp
Montreal, A8 |
Jan 29, 2025 Q4 2024 |
401,179
shares
|
$12.4 Million
0.04% of portfolio
|
Q4 2024
Reduced 6.96%
|
|
Finepoint Capital LP
Boston, MA |
Feb 13, 2025 Q4 2024 |
391,300
shares
|
$12.1 Million
0.96% of portfolio
|
Q4 2024
New holding
|
|
Eventide Asset Management, LLC
Boston, MA |
Feb 14, 2025 Q4 2024 |
375,924
shares
|
$11.6 Million
0.21% of portfolio
|
Q2 2024
New holding
|
|
Candriam S.C.A.
|
Feb 06, 2025 Q4 2024 |
360,710
shares
|
$11.1 Million
0.06% of portfolio
|
Q4 2024
Added 11.54%
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
352,498
shares
|
$10.9 Million
0.0% of portfolio
|
Q4 2024
Reduced 66.7%
|
|
Voya Investment Management LLC
Atlanta, GA |
Feb 14, 2025 Q4 2024 |
346,186
shares
|
$10.7 Million
0.01% of portfolio
|
Q4 2024
Added 1.08%
|
|
Ubs Asset Management Americas Inc
Chicago, IL |
Feb 14, 2025 Q4 2024 |
332,389
shares
|
$10.3 Million
0.0% of portfolio
|
Q4 2024
Reduced 4.72%
|
|
Manufacturers Life Insurance Company, The
Toronto, A6 |
Feb 14, 2025 Q4 2024 |
264,305
shares
|
$8.15 Million
0.01% of portfolio
|
Q4 2024
Added 2.66%
|
|
Barclays PLC
London, X0 |
Feb 13, 2025 Q4 2024 |
250,011
shares
|
$7.71 Million
0.0% of portfolio
|
Q4 2024
Reduced 2.22%
|
|
Qube Research & Technologies LTD
London, X0 |
Feb 14, 2025 Q4 2024 |
223,759
shares
|
$6.9 Million
0.01% of portfolio
|
Q4 2024
New holding
|
|
Connor, Clark & Lunn Investment Management Ltd.
|
Feb 10, 2025 Q4 2024 |
217,855
shares
|
$6.72 Million
0.03% of portfolio
|
Q4 2024
Added 0.38%
|
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
Feb 13, 2025 Q4 2024 |
211,200
shares
|
$6.51 Million
0.01% of portfolio
|
Q4 2024
Added 48.84%
|
|
Ubs Group Ag
|
Feb 14, 2025 Q4 2024 |
205,906
shares
|
$6.35 Million
0.0% of portfolio
|
Q4 2024
Added 15.76%
|
|
Raymond James Financial Inc
St. Petersburg, FL |
Feb 06, 2025 Q4 2024 |
198,907
shares
|
$6.13 Million
0.0% of portfolio
|
Q4 2024
New holding
|
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
Feb 14, 2025 Q4 2024 |
193,586
shares
|
$5.97 Million
0.0% of portfolio
|
Q4 2024
Added 18.59%
|